Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Novanta to replace Six Flags in the S&P 400 at open on 7/26 » 04:55
07/26/22
07/26
04:55
07/26/22
04:55
NOVT

Novanta

$147.76 /

-3.27 (-2.17%)

, SIX

Six Flags

$23.42 /

+0.285 (+1.23%)

, NTUS

Natus Medical

$32.97 /

+ (+0.00%)

Novanta (NOVT) will…

Novanta (NOVT) will replace Six Flags Entertainment (SIX) in the S&P MidCap 400, and Six Flags will replace Natus Medical (NTUS) in the S&P SmallCap 600 effective prior to the opening of trading on Tuesday, July 26. ArchiMed acquired Natus Medical in a deal that closed today. Six Flags Entertainment is more representative of the small-cap market space.

ShowHide Related Items >><<
SIX Six Flags
$23.42 /

+0.285 (+1.23%)

NTUS Natus Medical
$32.97 /

+ (+0.00%)

NOVT Novanta
$147.76 /

-3.27 (-2.17%)

NOVT Novanta
$147.76 /

-3.27 (-2.17%)

06/08/22
Baird to hold a conference
05/11/22 William Blair
Novanta upgraded to Outperform after 35% pullback at William Blair
05/11/22 William Blair
Novanta upgraded to Outperform from Market Perform at William Blair
SIX Six Flags
$23.42 /

+0.285 (+1.23%)

07/08/22 Citi
Six Flags downgraded to Neutral from Buy at Citi
06/24/22 Stifel
Six Flags price target lowered to $35 from $52 at Stifel
06/21/22 B. Riley
Six Flags downgraded to Neutral from Buy at B. Riley
05/13/22 Truist
Six Flags price target lowered to $32 from $46 at Truist
NTUS Natus Medical
$32.97 /

+ (+0.00%)

SIX Six Flags
$23.42 /

+0.285 (+1.23%)

NTUS Natus Medical
$32.97 /

+ (+0.00%)

NOVT Novanta
$147.76 /

-3.27 (-2.17%)

SIX Six Flags
$23.42 /

+0.285 (+1.23%)

SIX Six Flags
$23.42 /

+0.285 (+1.23%)

NTUS Natus Medical
$32.97 /

+ (+0.00%)

NOVT Novanta
$147.76 /

-3.27 (-2.17%)

Hot Stocks
Six Flags to replace Natus Medical in the S&P 600 at open on 7/26 » 04:55
07/26/22
07/26
04:55
07/26/22
04:55
SIX

Six Flags

$23.42 /

+0.285 (+1.23%)

, NTUS

Natus Medical

$32.97 /

+ (+0.00%)

, NOVT

Novanta

$147.76 /

-3.27 (-2.17%)

Novanta (NOVT) will…

Novanta (NOVT) will replace Six Flags Entertainment (SIX) in the S&P MidCap 400, and Six Flags will replace Natus Medical (NTUS) in the S&P SmallCap 600 effective prior to the opening of trading on Tuesday, July 26. ArchiMed acquired Natus Medical in a deal that closed today. Six Flags Entertainment is more representative of the small-cap market space.

ShowHide Related Items >><<
SIX Six Flags
$23.42 /

+0.285 (+1.23%)

NTUS Natus Medical
$32.97 /

+ (+0.00%)

SIX Six Flags
$23.42 /

+0.285 (+1.23%)

07/08/22 Citi
Six Flags downgraded to Neutral from Buy at Citi
06/24/22 Stifel
Six Flags price target lowered to $35 from $52 at Stifel
06/21/22 B. Riley
Six Flags downgraded to Neutral from Buy at B. Riley
05/13/22 Truist
Six Flags price target lowered to $32 from $46 at Truist
NTUS Natus Medical
$32.97 /

+ (+0.00%)

NOVT Novanta
$147.76 /

-3.27 (-2.17%)

06/08/22
Baird to hold a conference
05/11/22 William Blair
Novanta upgraded to Outperform after 35% pullback at William Blair
05/11/22 William Blair
Novanta upgraded to Outperform from Market Perform at William Blair
SIX Six Flags
$23.42 /

+0.285 (+1.23%)

NTUS Natus Medical
$32.97 /

+ (+0.00%)

NOVT Novanta
$147.76 /

-3.27 (-2.17%)

SIX Six Flags
$23.42 /

+0.285 (+1.23%)

SIX Six Flags
$23.42 /

+0.285 (+1.23%)

NTUS Natus Medical
$32.97 /

+ (+0.00%)

Hot Stocks
Six Flags to replace Natus Medical in the S&P 600 at open on 7/26 » 17:29
07/21/22
07/21
17:29
07/21/22
17:29
SIX

Six Flags

$23.09 /

+ (+0.00%)

, NTUS

Natus Medical

$32.97 /

+0.01 (+0.03%)

, NOVT

Novanta

$136.81 /

+5.16 (+3.92%)

Novanta (NOVT) will…

Novanta (NOVT) will replace Six Flags Entertainment (SIX) in the S&P MidCap 400, and Six Flags will replace Natus Medical (NTUS) in the S&P SmallCap 600 effective prior to the opening of trading on Tuesday, July 26. ArchiMed acquired Natus Medical in a deal that closed today. Six Flags Entertainment is more representative of the small-cap market space.

ShowHide Related Items >><<
SIX Six Flags
$23.09 /

+ (+0.00%)

NTUS Natus Medical
$32.97 /

+0.01 (+0.03%)

SIX Six Flags
$23.09 /

+ (+0.00%)

07/08/22 Citi
Six Flags downgraded to Neutral from Buy at Citi
06/24/22 Stifel
Six Flags price target lowered to $35 from $52 at Stifel
06/21/22 B. Riley
Six Flags downgraded to Neutral from Buy at B. Riley
05/13/22 Truist
Six Flags price target lowered to $32 from $46 at Truist
NTUS Natus Medical
$32.97 /

+0.01 (+0.03%)

NOVT Novanta
$136.81 /

+5.16 (+3.92%)

06/08/22
Baird to hold a conference
05/11/22 William Blair
Novanta upgraded to Outperform after 35% pullback at William Blair
05/11/22 William Blair
Novanta upgraded to Outperform from Market Perform at William Blair
SIX Six Flags
$23.09 /

+ (+0.00%)

NTUS Natus Medical
$32.97 /

+0.01 (+0.03%)

NOVT Novanta
$136.81 /

+5.16 (+3.92%)

SIX Six Flags
$23.09 /

+ (+0.00%)

SIX Six Flags
$23.09 /

+ (+0.00%)

NTUS Natus Medical
$32.97 /

+0.01 (+0.03%)

Hot Stocks
Novanta to replace Six Flags in the S&P 400 at open on 7/26 » 17:28
07/21/22
07/21
17:28
07/21/22
17:28
NOVT

Novanta

$136.81 /

+5.16 (+3.92%)

, SIX

Six Flags

$23.09 /

+ (+0.00%)

, NTUS

Natus Medical

$32.97 /

+0.01 (+0.03%)

Novanta (NOVT) will…

Novanta (NOVT) will replace Six Flags Entertainment (SIX) in the S&P MidCap 400, and Six Flags will replace Natus Medical (NTUS) in the S&P SmallCap 600 effective prior to the opening of trading on Tuesday, July 26. ArchiMed acquired Natus Medical in a deal that closed today. Six Flags Entertainment is more representative of the small-cap market space.

ShowHide Related Items >><<
SIX Six Flags
$23.09 /

+ (+0.00%)

NTUS Natus Medical
$32.97 /

+0.01 (+0.03%)

NOVT Novanta
$136.81 /

+5.16 (+3.92%)

06/08/22
Baird to hold a conference
05/11/22 William Blair
Novanta upgraded to Outperform after 35% pullback at William Blair
05/11/22 William Blair
Novanta upgraded to Outperform from Market Perform at William Blair
SIX Six Flags
$23.09 /

+ (+0.00%)

07/08/22 Citi
Six Flags downgraded to Neutral from Buy at Citi
06/24/22 Stifel
Six Flags price target lowered to $35 from $52 at Stifel
06/21/22 B. Riley
Six Flags downgraded to Neutral from Buy at B. Riley
05/13/22 Truist
Six Flags price target lowered to $32 from $46 at Truist
NTUS Natus Medical
$32.97 /

+0.01 (+0.03%)

SIX Six Flags
$23.09 /

+ (+0.00%)

NTUS Natus Medical
$32.97 /

+0.01 (+0.03%)

NOVT Novanta
$136.81 /

+5.16 (+3.92%)

SIX Six Flags
$23.09 /

+ (+0.00%)

SIX Six Flags
$23.09 /

+ (+0.00%)

NTUS Natus Medical
$32.97 /

+0.01 (+0.03%)

Hot Stocks
ArchiMed completes acquisition of Natus Medical » 09:15
07/21/22
07/21
09:15
07/21/22
09:15
NTUS

Natus Medical

$32.97 /

+0.05 (+0.15%)

Natus Medical announced…

Natus Medical announced that the MED Platform II fund of ArchiMed completed the acquisition of Natus. In accordance with the definitive merger agreement, Natus shareholders received $33.50 in cash for each share of Natus common stock. In conjunction with the closing of the transaction, Natus Chief Commercial Officer Austin Noll III was promoted to President of Natus.

ShowHide Related Items >><<
NTUS Natus Medical
$32.97 /

+0.05 (+0.15%)

NTUS Natus Medical
$32.97 /

+0.05 (+0.15%)

NTUS Natus Medical
$32.97 /

+0.05 (+0.15%)

Over a quarter ago
Earnings
Natus Medical reports Q1 EPS 22c, one- estimate 26c » 16:31
05/05/22
05/05
16:31
05/05/22
16:31
NTUS

Natus Medical

$33.04 /

-0.09 (-0.27%)

Reports Q1 revenue…

Reports Q1 revenue $119.8M, one- estimate $115.7M.

ShowHide Related Items >><<
NTUS Natus Medical
$33.04 /

-0.09 (-0.27%)

NTUS Natus Medical
$33.04 /

-0.09 (-0.27%)

NTUS Natus Medical
$33.04 /

-0.09 (-0.27%)

On The Fly
What You Missed On Wall Street This Morning » 12:08
04/18/22
04/18
12:08
04/18/22
12:08
QCOM

Qualcomm

$138.27 /

+1.34 (+0.98%)

, WEN

Wendy's

$20.24 /

-0.645 (-3.09%)

, SIRI

Sirius XM

$6.28 /

-0.18 (-2.79%)

, BIIB

Biogen

$214.00 /

+1.46 (+0.69%)

, DAL

Delta Air Lines

$42.34 /

-0.03 (-0.07%)

, UAL

United Airlines

$44.31 /

-0.82 (-1.82%)

, TWTR

Twitter

$47.36 /

+2.29 (+5.08%)

, BAC

Bank of America

$38.74 /

+1.21 (+3.22%)

, SYF

Synchrony

$39.40 /

+1.71 (+4.54%)

, DIDI

Symbol changed to DIDIY

$2.11 /

-0.37 (-14.95%)

, TSLA

Tesla

$996.25 /

+11.73 (+1.19%)

, CVM

CEL-SCI

$5.20 /

+1.91 (+58.05%)

, AAPL

Apple

$164.48 /

-0.79 (-0.48%)

, AXP

American Express

$183.15 /

+2.01 (+1.11%)

, CASA

Casa Systems

$6.45 /

+2.56 (+65.81%)

, ATER

Aterian

$5.94 /

+0.405 (+7.32%)

, NKTR

Nektar

$4.07 /

-2.1 (-34.04%)

, TGTX

TG Therapeutics

$7.01 /

-1.855 (-20.94%)

, RIVN

Rivian Automotive

$37.75 /

-2.86 (-7.04%)

, UPH

UpHealth

/

+

, SCHW

Charles Schwab

$75.57 /

-7.11 (-8.60%)

, BK

BNY Mellon

$45.65 /

-1.62 (-3.43%)

, RADA

Rada Electronic

$15.76 /

+0.72 (+4.79%)

, SFET

Safe-T

/

+

, INTC

Intel

$46.56 /

+0.91 (+1.99%)

, NTUS

Natus Medical

$33.57 /

+7.395 (+28.26%)

Get caught up quickly on…

ShowHide Related Items >><<
WEN Wendy's
$20.24 /

-0.645 (-3.09%)

UPH UpHealth
/

+

UAL United Airlines
$44.31 /

-0.82 (-1.82%)

TWTR Twitter
$47.36 /

+2.29 (+5.08%)

TSLA Tesla
$996.25 /

+11.73 (+1.19%)

TGTX TG Therapeutics
$7.01 /

-1.855 (-20.94%)

SYF Synchrony
$39.40 /

+1.71 (+4.54%)

SIRI Sirius XM
$6.28 /

-0.18 (-2.79%)

SFET Safe-T
/

+

SCHW Charles Schwab
$75.57 /

-7.11 (-8.60%)

RIVN Rivian Automotive
$37.75 /

-2.86 (-7.04%)

RADA Rada Electronic
$15.76 /

+0.72 (+4.79%)

QCOM Qualcomm
$138.27 /

+1.34 (+0.98%)

NTUS Natus Medical
$33.57 /

+7.395 (+28.26%)

NKTR Nektar
$4.07 /

-2.1 (-34.04%)

INTC Intel
$46.56 /

+0.91 (+1.99%)

DIDI Symbol changed to DIDIY
$2.11 /

-0.37 (-14.95%)

DAL Delta Air Lines
$42.34 /

-0.03 (-0.07%)

CVM CEL-SCI
$5.20 /

+1.91 (+58.05%)

CASA Casa Systems
$6.45 /

+2.56 (+65.81%)

BK BNY Mellon
$45.65 /

-1.62 (-3.43%)

BIIB Biogen
$214.00 /

+1.46 (+0.69%)

BAC Bank of America
$38.74 /

+1.21 (+3.22%)

AXP American Express
$183.15 /

+2.01 (+1.11%)

ATER Aterian
$5.94 /

+0.405 (+7.32%)

AAPL Apple
$164.48 /

-0.79 (-0.48%)

QCOM Qualcomm
$138.27 /

+1.34 (+0.98%)

04/18/22 Mizuho
Qualcomm price target lowered to $185 from $210 at Mizuho
04/18/22 SMBC Nikko
Qualcomm downgraded to Neutral from Outperform at SMBC Nikko
04/14/22 Credit Suisse
TSMC results may give 'tactical reprieve' to U.S. Semis, says Credit Suisse
04/05/22 JPMorgan
Qualcomm price target lowered to $205 from $240 at JPMorgan
WEN Wendy's
$20.24 /

-0.645 (-3.09%)

04/18/22 BMO Capital
Wendy's downgraded to Market Perform from Outperform at BMO Capital
04/14/22 Morgan Stanley
Wendy's price target lowered to $25 from $26 at Morgan Stanley
04/12/22 Citi
Wendy's initiated with a Neutral at Citi
03/23/22 Tigress Financial
Tigress Financial reiterates Buy on Wendy's, raises price target to $29
SIRI Sirius XM
$6.28 /

-0.18 (-2.79%)

04/18/22 Morgan Stanley
Sirius XM downgraded to Underweight at Morgan Stanley amid auto headwinds
04/18/22 Morgan Stanley
Sirius XM downgraded to Underweight from Equal Weight at Morgan Stanley
02/04/22 Citi
Citi opens 'positive Catalyst Watch' on Liberty SiriusXM, expects merger
01/14/22 JPMorgan
Sirius XM downgraded to Underweight on slowing car sales at JPMorgan
BIIB Biogen
$214.00 /

+1.46 (+0.69%)

04/18/22 Wells Fargo
Wells Fargo upgrades Biogen to Overweight, raises price target to $265
04/18/22 Wells Fargo
Biogen upgraded to Overweight from Equal Weight at Wells Fargo
04/12/22 Barclays
Biogen price target lowered to $219 from $235 at Barclays
04/08/22 William Blair
CMS decision to substantially limit Biogen opportunity, says William Blair
DAL Delta Air Lines
$42.34 /

-0.03 (-0.07%)

04/18/22 UBS
Delta Air Lines upgraded to Buy at UBS on better than expected Q2 TRASM
04/18/22 UBS
Delta Air Lines upgraded to Buy from Neutral at UBS
04/14/22 BofA
Delta Air Lines price target raised to $50 from $47 at BofA
04/14/22 Morgan Stanley
Delta Air Lines price target raised to $65 from $60 at Morgan Stanley
UAL United Airlines
$44.31 /

-0.82 (-1.82%)

04/18/22 UBS
UBS cuts United Airlines to Neutral, sees less compelling upside after 30% gain
04/18/22 UBS
United Airlines downgraded to Neutral from Buy at UBS
04/07/22 Barclays
United Airlines price target lowered to $50 from $52 at Barclays
03/18/22 Exane BNP Paribas
United Airlines upgraded to Neutral from Underperform at Exane BNP Paribas
TWTR Twitter
$47.36 /

+2.29 (+5.08%)

04/18/22 Wedbush
Wedbush sees three paths for Musk given Twitter's poison pill
04/17/22 Barclays
Barclays says Tesla soft Q2 likely overshadowed by Musk extracurricular activity
04/14/22 Wells Fargo
Wells Fargo says Musk's Twitter bid raises concerns for Tesla holders
04/14/22 KeyBanc
Twitter downgraded to Sector Weight from Overweight at KeyBanc
BAC Bank of America
$38.74 /

+1.21 (+3.22%)

04/18/22 Citi
Bank of America reported solid Q1 with no surprises, says Citi
04/05/22 Piper Sandler
Bank of America price target lowered to $51 from $57 at Piper Sandler
03/28/22 Morgan Stanley
Bank of America upgraded to Equal Weight from Underweight at Morgan Stanley
03/08/22 Baird
Bank of America upgraded to Neutral at Baird as bank risk/reward improves
SYF Synchrony
$39.40 /

+1.71 (+4.54%)

04/06/22 Wells Fargo
Synchrony price target lowered to $45 from $52 at Wells Fargo
04/06/22 Piper Sandler
Synchrony upgraded to Overweight from Neutral at Piper Sandler
03/28/22 Morgan Stanley
Morgan Stanley sees tail risks rising, downgrades Synchrony to Equal Weight
03/28/22 Morgan Stanley
Synchrony, MasterCard removed from 'Fresh Money Buy List' at Morgan Stanley
DIDI Symbol changed to DIDIY
$2.11 /

-0.37 (-14.95%)

03/16/22 US Tiger
China Internet sector upgraded to Outperform from Neutral at US Tiger
02/14/22 Bernstein
Didi initiated with an Outperform at Bernstein
07/28/21 Alliance Global Partners
Alliance Global Partners bullish on Aurora Mobile despite regulatory changes
07/28/21 Alliance Global Partners
iClick Interactive price target lowered to $15 from $21 at Alliance Global
TSLA Tesla
$996.25 /

+11.73 (+1.19%)

04/18/22 GLJ Research
This analyst sees Tesla shares 'tumbling' after Wednesday's earnings
04/18/22 Piper Sandler
Tesla price target lowered to $1,260 from $1,350 at Piper Sandler
CVM CEL-SCI
$5.20 /

+1.91 (+58.05%)

04/07/22 EF Hutton
CEL-SCI initiated with a Buy at EF Hutton
AAPL Apple
$164.48 /

-0.79 (-0.48%)

04/14/22 Craig-Hallum
II-VI price target lowered to $85 from $100 at Craig-Hallum
04/14/22 BTIG
BTIG cuts Enjoy Technology to Neutral on supply chain risk, cash burn
04/13/22 KeyBanc
Apple iPhone 13 demand remains healthy, SE disappoints, says KeyBanc
AXP American Express
$183.15 /

+2.01 (+1.11%)

04/11/22 JPMorgan
American Express downgraded to Neutral from Overweight at JPMorgan
03/28/22 Morgan Stanley
American Express price target raised to $223 from $218 at Morgan Stanley
03/17/22 BofA
American Express price target raised to $206 from $204 at BofA
03/17/22 Morgan Stanley
American Express positioned for multiple expansion, says Morgan Stanley
CASA Casa Systems
$6.45 /

+2.56 (+65.81%)

01/21/22 Macquarie
Casa Systems initiated with an Outperform at Macquarie
01/03/22 Northland
Harmonic price target raised to $17, named a top pick for 2022 at Northland
11/22/21 Northland
Casa Systems downgraded to Market Perform from Outperform at Northland
11/04/21 Barclays
Casa Systems price target lowered to $8 from $12 at Barclays
ATER Aterian
$5.94 /

+0.405 (+7.32%)

03/11/22 Alliance Global Partners
Aterian price target lowered to $4.50 from $9 at Alliance Global Partners
03/09/22 BTIG
Aterian price target lowered to $5 from $9 at BTIG
03/09/22 DA Davidson
Aterian price target lowered to $7 from $14 at DA Davidson
02/11/22 Alliance Global Partners
Aterian price target lowered to $9 from $13 at Alliance Global Partners
NKTR Nektar
$4.07 /

-2.1 (-34.04%)

04/18/22 Goldman Sachs
Nektar downgraded to Sell from Neutral at Goldman Sachs
04/18/22 Mizuho
Nektar price target lowered to $6 from $8 at Mizuho
03/18/22 Craig-Hallum
Nektar failure 'not necessarily' a read through to Cue, says Craig-Hallum
03/16/22 Canaccord
Nektar price target lowered to $6 from $25 at Canaccord
TGTX TG Therapeutics
$7.01 /

-1.855 (-20.94%)

04/18/22 H.C. Wainwright
H.C. Wainwright keeps Buy rating on TG Therapeutics after Ukoniq withdrawal
03/09/22 H.C. Wainwright
TG Therapeutics' FDA committee timing within expectations, says H.C. Wainwright
03/03/22 H.C. Wainwright
TG announced PDUFA goal date extension 'not a surprise,' says H.C. Wainwright
02/23/22 B. Riley
TG Therapeutics price target lowered to $35 from $49 at B. Riley
RIVN Rivian Automotive
$37.75 /

-2.86 (-7.04%)

04/18/22 Piper Sandler
Rivian Automotive price target lowered to $112 from $130 at Piper Sandler
04/11/22 Exane BNP Paribas
Rivian Automotive initiated with an Underperform at Exane BNP Paribas
04/06/22 RBC Capital
Rivian Automotive's stronger Q1 production to help rebuild confidence, says RBC
03/24/22 Mizuho
Rivian Automotive price target lowered to $95 from $100 at Mizuho
UPH UpHealth
/

+

03/31/22 Lake Street
Lake Street downgrades UpHealth to Hold, thinks credibility must be rebuilt
03/31/22 Northland
UpHealth price target lowered to $4.50 from $10.50 at Northland
03/31/22 Lake Street
UpHealth downgraded to Hold from Buy at Lake Street
01/05/22 Northland
UpHealth named a top pick for 2022 at Northland
SCHW Charles Schwab
$75.57 /

-7.11 (-8.60%)

04/14/22 JPMorgan
Charles Schwab price target lowered to $101 from $107 at JPMorgan
04/14/22 Citi
Charles Schwab price target lowered to $97 from $99 at Citi
04/13/22 Morgan Stanley
Morgan Stanley names Charles Schwab a 'Top Pick,' sees 'compelling' entry point
04/12/22 Compass Point
Charles Schwab upgraded to Buy at Compass Point on higher rate expectations
BK BNY Mellon
$45.65 /

-1.62 (-3.43%)

04/11/22 Citi
BNY Mellon downgraded to Neutral from Buy at Citi
04/07/22 Deutsche Bank
BNY Mellon price target lowered to $62 from $74 at Deutsche Bank
03/31/22 Wolfe Research
BNY Mellon downgraded to Peer Perform from Outperform at Wolfe Research
03/30/22 Goldman Sachs
BNY Mellon downgraded to Neutral from Buy at Goldman Sachs
RADA Rada Electronic
$15.76 /

+0.72 (+4.79%)

03/17/22 Alliance Global Partners
Rada Electronic downgraded to Neutral from Buy at Alliance Global Partners
01/12/22 Canaccord
Rada Electronic price target lowered to $14 from $16 at Canaccord
01/06/22 Alliance Global Partners
Rada Electronic price target lowered to $14 from $16 at Alliance Global Partners
11/03/21 Alliance Global Partners
Alliance Global Partners lowers Rada Electronic target to $16 after results
SFET Safe-T
/

+

01/31/22
Safe-T initiated with a Buy at Dawson James
09/23/21 Alliance Global Partners
Safe-T initiated with a Buy at Alliance Global Partners
INTC Intel
$46.56 /

+0.91 (+1.99%)

04/12/22 Citi
Citi sees 'another yellow flag' for Intel, reiterates Neutral
04/08/22 Truist
Intel price target lowered to $49 from $53 at Truist
03/31/22 Rosenblatt
AMD weakness on competitor downgrade a buying opportunity, says Rosenblatt
NTUS Natus Medical
$33.57 /

+7.395 (+28.26%)

WEN Wendy's
$20.24 /

-0.645 (-3.09%)

UPH UpHealth
/

+

UAL United Airlines
$44.31 /

-0.82 (-1.82%)

TWTR Twitter
$47.36 /

+2.29 (+5.08%)

TSLA Tesla
$996.25 /

+11.73 (+1.19%)

TGTX TG Therapeutics
$7.01 /

-1.855 (-20.94%)

SYF Synchrony
$39.40 /

+1.71 (+4.54%)

SIRI Sirius XM
$6.28 /

-0.18 (-2.79%)

SFET Safe-T
/

+

SCHW Charles Schwab
$75.57 /

-7.11 (-8.60%)

RIVN Rivian Automotive
$37.75 /

-2.86 (-7.04%)

RADA Rada Electronic
$15.76 /

+0.72 (+4.79%)

QCOM Qualcomm
$138.27 /

+1.34 (+0.98%)

NTUS Natus Medical
$33.57 /

+7.395 (+28.26%)

NKTR Nektar
$4.07 /

-2.1 (-34.04%)

INTC Intel
$46.56 /

+0.91 (+1.99%)

DIDI Symbol changed to DIDIY
$2.11 /

-0.37 (-14.95%)

DAL Delta Air Lines
$42.34 /

-0.03 (-0.07%)

CVM CEL-SCI
$5.20 /

+1.91 (+58.05%)

CASA Casa Systems
$6.45 /

+2.56 (+65.81%)

BK BNY Mellon
$45.65 /

-1.62 (-3.43%)

BIIB Biogen
$214.00 /

+1.46 (+0.69%)

BAC Bank of America
$38.74 /

+1.21 (+3.22%)

AXP American Express
$183.15 /

+2.01 (+1.11%)

ATER Aterian
$5.94 /

+0.405 (+7.32%)

AAPL Apple
$164.48 /

-0.79 (-0.48%)

  • 13
    Jan
  • 10
    Nov
  • 05
    Oct
  • 30
    Jun
  • 09
    Jun
WEN Wendy's
$20.24 /

-0.645 (-3.09%)

UAL United Airlines
$44.31 /

-0.82 (-1.82%)

TWTR Twitter
$47.36 /

+2.29 (+5.08%)

TSLA Tesla
$996.25 /

+11.73 (+1.19%)

SYF Synchrony
$39.40 /

+1.71 (+4.54%)

SIRI Sirius XM
$6.28 /

-0.18 (-2.79%)

SCHW Charles Schwab
$75.57 /

-7.11 (-8.60%)

RIVN Rivian Automotive
$37.75 /

-2.86 (-7.04%)

QCOM Qualcomm
$138.27 /

+1.34 (+0.98%)

INTC Intel
$46.56 /

+0.91 (+1.99%)

DIDI Symbol changed to DIDIY
$2.11 /

-0.37 (-14.95%)

DAL Delta Air Lines
$42.34 /

-0.03 (-0.07%)

CVM CEL-SCI
$5.20 /

+1.91 (+58.05%)

BK BNY Mellon
$45.65 /

-1.62 (-3.43%)

BIIB Biogen
$214.00 /

+1.46 (+0.69%)

BAC Bank of America
$38.74 /

+1.21 (+3.22%)

AXP American Express
$183.15 /

+2.01 (+1.11%)

AAPL Apple
$164.48 /

-0.79 (-0.48%)

WEN Wendy's
$20.24 /

-0.645 (-3.09%)

UPH UpHealth
/

+

UAL United Airlines
$44.31 /

-0.82 (-1.82%)

TWTR Twitter
$47.36 /

+2.29 (+5.08%)

TSLA Tesla
$996.25 /

+11.73 (+1.19%)

TGTX TG Therapeutics
$7.01 /

-1.855 (-20.94%)

SYF Synchrony
$39.40 /

+1.71 (+4.54%)

SIRI Sirius XM
$6.28 /

-0.18 (-2.79%)

SCHW Charles Schwab
$75.57 /

-7.11 (-8.60%)

RIVN Rivian Automotive
$37.75 /

-2.86 (-7.04%)

RADA Rada Electronic
$15.76 /

+0.72 (+4.79%)

QCOM Qualcomm
$138.27 /

+1.34 (+0.98%)

NKTR Nektar
$4.07 /

-2.1 (-34.04%)

INTC Intel
$46.56 /

+0.91 (+1.99%)

DIDI Symbol changed to DIDIY
$2.11 /

-0.37 (-14.95%)

DAL Delta Air Lines
$42.34 /

-0.03 (-0.07%)

BK BNY Mellon
$45.65 /

-1.62 (-3.43%)

BIIB Biogen
$214.00 /

+1.46 (+0.69%)

BAC Bank of America
$38.74 /

+1.21 (+3.22%)

AXP American Express
$183.15 /

+2.01 (+1.11%)

ATER Aterian
$5.94 /

+0.405 (+7.32%)

AAPL Apple
$164.48 /

-0.79 (-0.48%)

WEN Wendy's
$20.24 /

-0.645 (-3.09%)

UAL United Airlines
$44.31 /

-0.82 (-1.82%)

TWTR Twitter
$47.36 /

+2.29 (+5.08%)

TSLA Tesla
$996.25 /

+11.73 (+1.19%)

SYF Synchrony
$39.40 /

+1.71 (+4.54%)

SIRI Sirius XM
$6.28 /

-0.18 (-2.79%)

SCHW Charles Schwab
$75.57 /

-7.11 (-8.60%)

RIVN Rivian Automotive
$37.75 /

-2.86 (-7.04%)

QCOM Qualcomm
$138.27 /

+1.34 (+0.98%)

NKTR Nektar
$4.07 /

-2.1 (-34.04%)

INTC Intel
$46.56 /

+0.91 (+1.99%)

DIDI Symbol changed to DIDIY
$2.11 /

-0.37 (-14.95%)

DAL Delta Air Lines
$42.34 /

-0.03 (-0.07%)

CASA Casa Systems
$6.45 /

+2.56 (+65.81%)

BIIB Biogen
$214.00 /

+1.46 (+0.69%)

BAC Bank of America
$38.74 /

+1.21 (+3.22%)

AXP American Express
$183.15 /

+2.01 (+1.11%)

ATER Aterian
$5.94 /

+0.405 (+7.32%)

AAPL Apple
$164.48 /

-0.79 (-0.48%)

Earnings
Natus Medical to no longer update financial guidance » 07:03
04/18/22
04/18
07:03
04/18/22
07:03
NTUS

Natus Medical

$26.07 /

+0.21 (+0.81%)

Due to the announced…

Due to the announced transaction, the Company will no longer update financial guidance.

ShowHide Related Items >><<
NTUS Natus Medical
$26.07 /

+0.21 (+0.81%)

NTUS Natus Medical
$26.07 /

+0.21 (+0.81%)

Earnings
Natus Medical sees Q1 revenue $119.8M vs. $114.9M last year » 07:02
04/18/22
04/18
07:02
04/18/22
07:02
NTUS

Natus Medical

$26.07 /

+0.21 (+0.81%)

Revenue for the first…

Revenue for the first quarter 2022 was $119.8 million, up 4.3% compared to $114.9 million in the first quarter 2021. During the first quarter of 2022, Natus incurred $3.4 million of extraordinary supply chain costs associated with acquiring semiconductors. The Company ended the quarter with $84 million in cash and no debt, up from $75.6 million at the beginning of the quarter. The Company will release its full 2022 first quarter financial results after the close of the market on Thursday, May 5th.

ShowHide Related Items >><<
NTUS Natus Medical
$26.07 /

+0.21 (+0.81%)

Hot Stocks
Natus Medical to be acquired by ArchiMed Group for $33.50 per share » 07:01
04/18/22
04/18
07:01
04/18/22
07:01
NTUS

Natus Medical

$26.07 /

+0.21 (+0.81%)

Natus Medical announced…

Natus Medical announced today that it has entered into a definitive agreement to be acquired by an affiliate of ArchiMed for approximately $1.2 billion. Under the terms of the agreement, Natus shareholders will receive $33.50 in cash for each share of Natus common stock, representing a 29% premium to the closing price of the Company's common stock on April 14, 2022. Under the terms of the agreement, Natus shareholders will receive $33.50 in cash for each share of Natus common stock they own. The transaction has fully committed equity financing from funds affiliated with ArchiMed and fully committed debt financing, and there are no financing conditions associated with the transaction. Natus's Board of Directors has unanimously approved the merger agreement with ArchiMed and recommends that Natus's shareholders adopt the merger agreement. In connection with the transaction, the Company will prepare a proxy statement to be filed with the U.S. Securities and Exchange Commission. Following any review by the SEC, a definitive proxy statement will be mailed to shareholders of Natus. Natus expects to hold a Special Meeting of Shareholders to consider and vote on the proposed merger and the merger agreement as soon as practicable after the mailing of the proxy statement. The transaction is expected to close in the third quarter of 2022, subject to customary closing conditions, including approval by Natus shareholders and receipt of regulatory approvals. Upon completion of the transaction, Natus will become a private company and Natus shares will no longer be listed on any public market. Under the terms of the merger agreement, Natus may solicit proposals from third parties for a period of 30 days continuing through May 17, 2022, and in certain cases for a period of 35 days continuing through May 22, 2022. In addition, Natus may, at any time prior to receipt of shareholder approval, subject to the provisions of the merger agreement, respond to unsolicited proposals that constitute or would reasonably be expected to lead to a superior proposal. Natus will have the right to terminate the merger agreement with ArchiMed to enter into a superior proposal subject to the terms and conditions of such agreement, including payment of a customary termination fee. There can be no assurance that the solicitation process will result in a superior proposal or that any other transaction will be approved or completed. Natus does not intend to disclose developments with respect to this solicitation process unless and until its Board of Directors determines such disclosure is appropriate or is otherwise required.

ShowHide Related Items >><<
NTUS Natus Medical
$26.07 /

+0.21 (+0.81%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.